Free tool
Stocks listed on Nasdaq GS
We cover 33 companies listed on Nasdaq GS. The median market value in the group is $1.87B. Across the group, the median move over the past trading day is −0.07%. 100% of the 32 with a 200-day average trade above it. Price change over the past year runs from +0.4% to +290.3% across the middle 80 percent of the group, with a median of +73.5%.
Other lists in this group
Table
33 of 1,279 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| AMGN | Amgen Inc. | $440.34 | +12.02% | +36.35% | +56.24% |
| ARGX | argenx SE | $1,047.10 | +20.05% | +24.66% | +47.90% |
| NTRA | Natera, Inc. | $338.45 | +34.19% | +47.90% | +107.59% |
| ILMN | Illumina, Inc. | $224.84 | +16.51% | +67.35% | +125.88% |
| HALO | Halozyme Therapeutics, Inc. | $107.06 | +28.29% | +52.27% | +46.30% |
| RGEN | Repligen Corporation | $180.30 | +24.05% | +9.70% | +51.67% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $84.84 | +1.17% | +81.55% | +179.08% |
| TXG | 10x Genomics, Inc. | $64.26 | +36.58% | +286.64% | +358.35% |
| CAI | Caris Life Sciences, Inc. | $26.82 | +72.03% | −0.59% | −29.83% |
| HTFL | Heartflow, Inc. | $48.94 | +91.25% | +68.93% | +40.79% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $37.08 | +89.67% | +224.69% | +292.38% |
| IDYA | IDEAYA Biosciences, Inc. | $41.58 | +14.99% | +22.84% | +66.32% |
| ABCL | AbCellera Biologics Inc. | $12.24 | +131.38% | +256.85% | +181.38% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $8.90 | +29.74% | +161.76% | +281.97% |
| AVAH | Aveanna Healthcare Holdings Inc. | $13.62 | +37.71% | +68.56% | +73.50% |
| ZYME | Zymeworks Inc. | $29.31 | +29.61% | +10.09% | +96.28% |
| VIR | Vir Biotechnology, Inc. | $11.08 | +25.20% | +86.53% | +111.85% |
| INBX | Inhibrx Biosciences, Inc. | $125.34 | +57.30% | +67.03% | +357.45% |
| SPTX | Seaport Therapeutics, Inc. | $27.84 | +39.90% | +40.32% | +40.32% |
| CGEM | Cullinan Therapeutics, Inc. | $22.85 | +30.80% | +125.79% | +188.15% |
| VREX | Varex Imaging Corporation | $18.48 | +66.04% | +58.63% | +61.40% |
| SOPH | SOPHiA GENETICS SA | $8.53 | +53.14% | +82.66% | +156.16% |
| ASMB | Assembly Biosciences, Inc. | $35.42 | +38.52% | +4.95% | +36.81% |
| PRLD | Prelude Therapeutics Incorporated | $6.56 | +41.38% | +140.29% | +412.50% |
| SENS | Senseonics Holdings, Inc. | $9.34 | +90.22% | +58.57% | +0.43% |
| SGHT | Sight Sciences, Inc. | $8.37 | +57.92% | +11.90% | +97.87% |
| CARL | Carlsmed, Inc. | $16.18 | +31.44% | +39.12% | +16.40% |
| CCRN | Cross Country Healthcare Inc | $13.25 | 0.00% | +64.39% | +0.38% |
| CPIX | Cumberland Pharmaceuticals Inc. | $8.97 | +69.86% | +125.38% | +163.82% |
| BMEA | Biomea Fusion, Inc. | $1.71 | +36.80% | +27.61% | −8.06% |
| LUNG | Pulmonx Corporation | $2.50 | +100.00% | +8.70% | +34.41% |
| KYNB | Kyntra Bio, Inc. | $8.11 | +16.20% | −11.52% | −22.66% |
| TXMD | TherapeuticsMD, Inc. | $2.28 | +10.68% | +38.18% | +103.57% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.